amph_ex{num}_1 
exhibit {num} 
amphastar pharmaceuticals , inc . purchases international medication systems ( uk ) limited from ucb pharma gmbh 
rancho cucamonga , ca – august {num} {num} – amphastar pharmaceuticals , inc . ( nasdaq : amph ) ( " amphastar " or the " company " ) , announced today that , through its wholly owned uk subsidiary , amphastar uk limited , acquired a uk based corporation , international medication systems ( uk ) limited , including its product trademarks , and other related product assets , as well as marketing authorizations for thirty-three products in the uk , ireland , australia , and new zealand , representing eleven different injectable chemical entities , from ucb pharma gmbh for ${num} million . the products are generic injectables containing the following active ingredients ; adrenaline , amiodarone , atropine , calcium chloride , furosemide , glucose , lidocaine , magnesium sulphate , morphine , naloxone and sodium bicarbonate . amphastar plans to transfer the products to its facilities in california . the transfer will require uk mhra and other related regulatory agency approval before the products can be re-launched . 
amphastar's ceo , dr . jack zhang , ph . d . stated , " we are very happy to be able to expand our presence into the international market with this transaction and to reunite the uk ims entity with the us ims entity . " 
management will address all questions regarding this transaction on the second quarter earnings call scheduled for august {num} {num} at 2 : {num} p . m . pacific time . 
to access the conference call , dial toll-free ( {num} ) {num}-{num} or ( {num} ) {num}-{num} for international callers , five minutes before the conference . the passcode for the conference call is {num} 
the call can also be accessed on the investors page on the company's website www . amphastar . com . 
company information 
amphastar is a specialty pharmaceutical company that focuses primarily on developing , manufacturing , marketing , and selling technically-challenging generic and proprietary injectable , inhalation , and intranasal products . additionally , the company sells insulin active pharmaceutical ingredient products . most of the company's finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers . more information is available at the company's website at www . amphastar . com . 
forward looking statements 
all statements in this press release that are not historical are forward-looking statements , including , among other things , statements relating to the company's expectations regarding sales and marketing of its products , the timing of fda filings and other matters related to its pipeline 
of product candidates and other future events . these statements are not historical facts but rather are based on amphastar's current expectations , estimates , and projections regarding amphastar's business , operations , and other similar or related factors . words such as " may , " " will , " " could , " " would , " " should , " " anticipate , " " predict , " " potential , " " continue , " " expects , " " intends , " " plans , " " projects , " " believes , " " estimates , " and other similar or related expressions are used to identify these forward-looking statements , although not all forward-looking statements contain these words . you should not place undue reliance on forward-looking statements because they involve known and unknown risks , uncertainties , and assumptions that are difficult or impossible to predict and , in some cases , beyond amphastar's control . actual results may differ materially from those in the forward-looking statements as a result of a number of factors , including those described in amphastar's filings with the securities and exchange commission . amphastar undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future , even if new information becomes available . 
contact information : 
amphastar pharmaceuticals , inc . 
bill peters 
chief financial officer 
{enum} {num}-{num} 
